1. Home
  2. UNB vs TLSA Comparison

UNB vs TLSA Comparison

Compare UNB & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Union Bankshares Inc.

UNB

Union Bankshares Inc.

SELL

Current Price

$22.96

Market Cap

121.6M

Sector

Finance

ML Signal

SELL

Logo Tiziana Life Sciences Ltd.

TLSA

Tiziana Life Sciences Ltd.

N/A

Current Price

$0.68

Market Cap

145.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
UNB
TLSA
Founded
1891
2013
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
121.6M
145.1M
IPO Year
1999
2017

Fundamental Metrics

Financial Performance
Metric
UNB
TLSA
Price
$22.96
$0.68
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
★ $8.11
AVG Volume (30 Days)
4.1K
★ 605.9K
Earning Date
10-21-2026
05-01-2026
Dividend Yield
★ 6.38%
N/A
EPS Growth
★ 25.52
N/A
EPS
★ 1.25
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$18.22
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$20.65
$0.62
52 Week High
$26.41
$1.90

Technical Indicators

Market Signals
Indicator
UNB
TLSA
Relative Strength Index (RSI) 38.88 29.82
Support Level N/A N/A
Resistance Level $24.16 $1.21
Average True Range (ATR) 0.40 0.08
MACD 0.02 -0.04
Stochastic Oscillator 10.26 16.20

Price Performance

Historical Comparison
UNB
TLSA

About UNB Union Bankshares Inc.

Union Bankshares Inc operates as a community bank in the financial services industry. It offers retail and commercial banking services to its customers through its branches, ATMs, telebanking, and internet banking systems. The Company has one definable business segment, Union Bank, which provides full retail, commercial, municipal banking, and wealth management and trust services throughout its 18 branch banking locations, three loan centers, and several ATMs covering northern Vermont and northern New Hampshire. In addition, it also offers fiduciary and asset management services through its Asset Management Group.

About TLSA Tiziana Life Sciences Ltd.

Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. The company's clinical pipeline includes drug assets for Non-Active Secondary Progressive Multiple Sclerosis, Multiple System Atrophy, Alzheimer's, and Amyotrophic Lateral Sclerosis. The company's mission is to design and deliver next-generation immunotherapies for neurodegenerative and neuroinflammatory diseases. The company's main immunotherapeutic candidate, Foralumab (TZLS-401), is being developed for Non-Active Secondary Progressive Multiple Sclerosis, Alzheimer's, and other CNS indications.

Share on Social Networks: